To test the effects of circPRDM4 on HCC growth and immune evasion in vivo, we constructed a humanized mouse model as illustrated in Fig. 5A. Tumor infiltrating CD8+ T cells from HCC patients were subsequently adoptively transferred into immune-compromised NCG mice harboring HCC PDX. This evidence concerns the gene CD8A and hepatocellular carcinoma.